| Variables | Number of patients (n) | Percentage (%) |
| Age range (years) |
|
|
| <40 | 69 | 78.4 |
| ≥40 | 19 | 21.6 |
| Antecedent pregnancy | ||
| Molar | 87 | 98.9 |
| Term | 2 | 1.1 |
| Interval from index pregnancy (months) | ||
| <4 | 46 | 52.3 |
| ≥4 | 42 | 47.7 |
| Largest tumour size in cm | ||
| 0 | 60 | 68.2 |
| <3 | 28 | 31.8 |
| Pre-treatment serum hCG level (UI/ml) | ||
| <100,000 | 79 | 89.8 |
| ≥100,000 | 9 | 10.2 |
| FIGO stage | ||
| I | 82 | 93.2 |
| II | 6 | 6.8 |
| III | 3 | 2,1 |
| Risk score | ||
| <4 | 60 | 68.2 |
| ≥4 | 28 | 31.8 |